Abstract
We present the case of a 64 year-old female patient, with a clearly positive family history of venous thromboembolism (VTE), multiple VTE episodes (massive pulmonary embolism, ovarian venous plexus thrombosis, deep venous thrombosis with submassive pulmonary embolism and second deep venous thrombosis) and myocardial infarction.
Laboratory tests revealed the resistance to the activated protein C, elevated FVIII and PAI-1. The patient was found to be a heterozygous carrier of FV Leiden, MTHFR C677T and PAI-1 4G/5G mutations. She was diagnosed with essential thrombocythemia at the age of 60.
The thirty-three-year follow-up of our patient and detection of recurrent thrombotic episodes in the light of multiple coagulation defects with proved acquired risk factors, contributes to the risk stratification in the group of patients with very high risk. In case of our patient, we stress inadequacy of widely-accepted standard prevention measures. In our opinion, patients with very high risk require additional mechanic and specific medicament methods of VTE prevention.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bertna MR. Molecular risk factors for thrombosis. Thromb Haemost 1999;82(2):601–609.
Mideldorp S, Büller HR, Prins MH, Hirsh J. Aproach to the thrombophilic patient. In: Colman RW, ed. Hemostasis and Thrombosis, Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:1085–1100.
Dawson S, Hamsten A, Wiman B, Heney E, Humphreis S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator-1 activity. Artherioscler Thromb 1991;11:183–190.
Marder VJ, Matei DE. Hereditary and acquired thrombophilic syndrome. In: Colman RW, ed. Hemostasis and Thrombosis, Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001:1243–1275.
Caprimi JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001;38(5):12–19.
Eldor A. Unexplored territories in the nonsurgical patient: A look at pregnancy. Semin Hematol 2001;38(5):39–48.
Rosendal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999;82(2):610–619.
Hoffman R, Primary thrombocythemia. In: Hoffman R, ed. Hematology, Basic Principles and Practicem. New York: Churchill Livingstone, 2000;1192.
Wille-Jorgensen P. Potential role of new therapies in deep vein thrombosis prophylaxis. Semin Hematol 2001;38(5):20–27.
Alpert J, Dalen J. Pulmonary embolism. In: Alexander W, ed. Schalant R, Fuster V. Hurst’s the Heart. New York: McGrow-Hill, 1998;1719–1738.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antonijevic, N., Stanojevic, M., Milosevic, R. et al. Combined Thrombophilic Risk Factors and Essential Thrombocythemia in Patient with Recurrent Venous Thromboembolic Episodes—Thirty-Three-Year Follow-Up. J Thromb Thrombolysis 19, 93–95 (2005). https://doi.org/10.1007/s11239-005-0783-1
Issue Date:
DOI: https://doi.org/10.1007/s11239-005-0783-1